SCO-792
Phenylketonuria, Maple syrup urine disease, Homocystinuria, Nephrotic syndrome, ADPKD
PreclinicalActive
Key Facts
Indication
Phenylketonuria, Maple syrup urine disease, Homocystinuria, Nephrotic syndrome, ADPKD
Phase
Preclinical
Status
Active
Company
About SCOHIA PHARMA
A Japanese bioventure developing innovative small molecule drugs for metabolic, cardiovascular, and renal diseases through a diversified pipeline and strategic collaborations.
View full company profile